Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Drug Infusion Systems Market Size?

The market size for drug infusion systems has seen significant expansion in the past few years. The projected growth for this market is from $13.42 billion in 2024 to $14.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors that have contributed to growth during the historic period include the transition to electronic infusion devices, a higher incidence of chronic conditions, improvements in patient care, the rise of home-based infusion therapy, and the growth of ambulatory care environments.

Expectations are high for substantial growth in the drug infusion systems industry in the forthcoming years, with the market predicted to rise to $20.23 billion by 2029 boasting a compound annual growth rate (CAGR) of 9.2%. The foreseeable expansion over this period is largely due to a transition toward disposable apparatus, escalating rates of persistent health conditions, the proliferation of outpatient care services, tailor-made medication and adaptable dosing, coupled with inflated demand for medical care at home. The forecast period will also see significant trends emerge such as remote tracking and wireless connectivity, integration with digital health records, innovative smart pump technology, personalized and flexible dosing, and less invasive infusion practices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

Which Factors Are Steering Growth In The Drug Infusion Systems Market?

The escalation in occurrences of chronic conditions is anticipated to spur the advancement of the drug infusion system market. Conditions such as cancer, diabetes, cardiovascular and autoimmune disorders often necessitate long-term or persistent infusion therapy. For patients with these ailments, drug infusion systems provide a safe, efficient, and efficacious method for medication administration. Compared to wealthier nations, the rate of occurrences has been escalating more swiftly in lesser to middle-income countries. Diabetes is a primary cause of renal failure, heart attacks, strokes, blindness, and lower limb amputation. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a US-based agency, reported that there is a rising number of Americans coping with numerous chronic conditions, with 42% having two or more and 12% having five or more. Hence, this surge in necessity due to the escalating prevalence of chronic illnesses propels the growth of the drug infusion system market.

How Is The Drug Infusion Systems Market Organized By Different Segments?

The drug infusion systemsmarket covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

What Current And Upcoming Trends Are Shaping The Drug Infusion Systems Market?

Prominent enterprises in the drug infusion systems market are investing in high-end technologies such as cloud-based infusion management systems to optimize patient care, enhance precision, and simplify administering infusion treatments. These cloud-based systems serve as virtual platforms enabling the overseeing, facilitation, and tracking of medicinal infusion via online cloud networks. For instance, Eitan Medical, a renowned US-based company noted for its cutting-edge infusion therapy and pharmaceutical delivery solutions, unveiled Eitan Insights in June 2023. This new cloud-based infusion management system caters to the specific demands of home and niche infusions. Eitan Insights offers immediate data and analytical insights to medical professionals, empowering them to remotely supervise patients and modify treatment regimens as required. By minimizing the possibility of mistakes and ensuring compliance with recommended procedures, this system boosts the safety of medication administration.

Who Are The Most Influential Companies In The Drug Infusion Systems Market?

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Which Region Dominates The Drug Infusion Systems Market Today?

North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model